Check out our COVID-19 dedicated page for tenders related to medical equipment needs.
231901-2021 - Belgium-Brussels: Production, Priority-purchasing Options and Supply of Covid-19 Vaccines, Including Adapted Vaccines to SARS-CoV-2 Variants and Paediatric Formulations of such Vaccines for EU Member States
Greece-Athens: Research and experimental development services
Contract award notice
Results of the procurement procedure
Section I: Contracting authority
KEMEA is appointed as the lead procurer on behalf of the group of procurers listed in 1.1 above. The applicable national procurement law is Greek.
Section II: Object
Scientific High-throughput and Unified Toolkit for Trace Analysis by forensic Laboratories in Europe (SHUTTLE) Pre-Commercial Procurement
This contract notice invites interested operators to submit tenders to the procurement.
This PCP aims to trigger new solutions to be developed and tested to address the following challenge: PCP for innovation activity to design and build a cost-effective, open machine integrating a rich toolkit for automated trace evidence analysis which will provide scientific evidence in a high-throughput manner; this machine and toolkit will be used in a unified way, so that cross-border and cross-laboratory collaboration will be improved and methodology and quality assurance accreditation in different laboratories will be homogenised.
At least 50 % of the contracted R&D services in EU Member States or Horizon 2020 associated countries. See RFT (section 3.4) for full details.
The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. Specific requirements for innovation procurement (PCP/PPI) supported by Horizon 2020 grants apply. The PCP will be implemented by means of a framework agreement with specific contracts for each of the 3 R&D phases. The three phases are:
1) R&D up to solution design (6 months);
2) R&D up to prototype development (9 months);
3) R&D up to original development,validation and testing of a limited set of first products (6 months).
After each phase, intermediate evaluations will be carried out to progressively select the best of the competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase. The procurement procedure is expected to start by September 2019 and end by October 2021. The selected operators will retain ownership of the Intellectual Property Rights (IPRs) that they will generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions (i.e beyond the procurers).
This procurement receives funding from the European Union’s Horizon 2020 Research and Innovation Programme, under grant agreement No 786913 (see https://www.shuttle-pcp.eu/project-at-a-glance/fact-sheet/) The EU has given a grant for this procurement, but is not participating as a contracting authority in the procurement.
Participation in the open market consultation that was held as part of the preparation for this procurement is not a prerequisite for submitting a tender.
This PCP is exempted from the EU public procurement directives and the national laws that implement them.
KEMEA is acting as the Contracting Authority on behalf of the SHUTTLE Buyers' Group.
Section IV: Procedure
Section V: Award of contract
Scientific High-throughput and Unified Toolkit for Trace Analysis by Forensic Laboratories in Europe (SHUTTLE) Pre-Commercial Procurement
Scientific High-throughput and Unified Toolkit for Trace analysis by forensic Laboratories in Europe (SHUTTLE) Pre-Commercial Procurement
Section VI: Complementary information
The procurement is exempted from the EU public procurement directives (including the EU procurement remedies Directives 89/665/EEC and 92/13/EEC) and the national laws that implement them.
All possible complaints during the tendering process will be submitted to the Technical Board (TB). The TB is responsible to evaluate the complaints and to submit its opinion to the Contracting Board (CB) for final decision. The complaints will be submitted within 10 days following the notification of the final decision of the CB.
Any dispute or claim arising in connection with the execution of the contracts shall be heard by the Greek courts.
Submission of complaints shall not lead to unreasonable delays in the evaluation and award procedures.